- June 17, 2021
2:00 PM - 3:30 PM ET
Otis Brawley, M.D. – Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University. Dr. Brawley is a board-certified medical oncologist and an epidemiologist cancer screening and prevention, and leads a broad research effort of cancer health disparities at the Johns Hopkins, an authority on School of Medicine, Bloomberg School of Public Health and the Sidney Kimmel Comprehensive Cancer Center.
John D. Carpten, PhD - Internationally recognized expert in genome science, and possesses unique training in multiple disciplines including germ-line genetics for disease risk and predisposition, somatic cancer genomics, health disparities research, cell biology, functional genomics, and precision medicine. Dr. Carpten’s primary research program centers around the development and application of cutting-edge genomic technologies and bioinformatics analysis in search of germ-line and somatic alterations that are associated with cancer risk and tumor characteristics. Dr. Carpten has also been an early pioneer in the understanding the role of biology in disparate cancer incidence and mortality rates seen among underrepresented populations. In 2016, he was recruited by the University of Southern California Keck School of Medicine, to build and chair a new Department and Institute of Translational Genomics.
Chris Draft - Founder, President, and CEO of the Chris Draft Family Foundation whose mission has been to empower families to lead healthy lifestyles. He is also the Co-Founder of Team Draft, leading the creation of a national campaign that is changing the face of lung cancer. He is an internationally recognized speaker, community leader, and family and character advocate who serves as an NFL Ambassador and a national spokesperson on many health-related issues, including the care and treatment of asthma, from which he suffers, and lung cancer, the disease that claimed the life of his wife, Keasha in 2011.
Ahmed Elmi, MPH - Program Officer for the National Institutes of Health All of Us Research Program’s engagement division. He works closely with the chief of the engagement division to manage the community engagement awardees and community and provider initiatives to build a robust set of community and provider organizations who can advance the priorities of the program. Ahmed has more than 20 years of experience managing and coordinating public health, training, and research programs in both the public and private sectors, including work for the City of Alexandria, Virginia, the state of Maryland, and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Brian M. Rivers, PhD, MPH - Director of the Cancer Health Equity Institute at Morehouse School of Medicine. Dr. Rivers is nationally and internationally recognized as a leader in cancer disparities research and has worked to identify the sociocultural, behavioral, and environmental determinants of cancer health disparities and translated this information into interventions to improve cancer equity among racially diverse populations and medically underserved groups.
Robert Winn, M.D. - Director of the NCI-designated Virginia Commonwealth University (VCU) Massey Cancer Center. An accomplished physician-scientist, Dr. Winn is a pulmonologist whose scholarship has focused on lung cancer, health disparities, and community-based health care. His basic science research, which has been supported by multiple National Institutes of Health and Veterans Affairs Merit awards, focuses on the mechanisms that drive the proliferation of cancer and on the role of cellular senescence in lung cancer. Dr. Winn is committed to developing methods to eliminate health disparities and has received national and international acclaim for his efforts to empower underserved patient populations, improve health-care delivery, and ensure equal access to cutting-edge medical treatments.
Rea Blakey - Associate Director for External Outreach and Engagement, Oncology Center of Excellence, US Food and Drug Administration. Rea Blakey serves as a liaison leader for patients, advocacy groups, cancer community organizations and others interested in influencing oncology-related medical product regulatory decision-making. Rea leads OCE’s Project Community external outreach and engagement initiative which encompasses all interested cancer community stakeholders as well as focusing on increasing minority and under-represented population awareness and participation in cancer clinical trials.
“National Black Family Cancer Awareness Week: Engaging the Generations” #BlackFamCan is a new Oncology Center of Excellence (OCE) Project Community initiative. In accordance with the January 20, 2021 Presidential Executive Order “Advancing Racial Equity and Support for Underserved Communities Through the Federal Government”, and in recognition of the 50th anniversary of the National Cancer Act, OCE is engaging NCI-designated Cancer Centers, cancer advocacy groups, patients, social and community organizers, families and friends.
Please register to attend the OCE Conversations on Cancer: “National Black Family Cancer Awareness Week: Engaging the Generations” public panel discussion as we launch National Black Family Cancer Awareness Week. Learn from thought leaders in cancer research, patient advocacy, and health equity. The ultimate mission of National Black Family Cancer Awareness Week #BlackFamCan is to increase cancer clinical trial awareness and to build knowledge of and participation in national genetic databases for cancer research.
A free-of-charge webcast of this public panel discussion will be provided via Zoom.gov. Registration for the webcast is required at the link above.
FDA plans to post archived webcasts after the meeting, however, in cases where the transmission was not successful, archived webcasts will not be available.
For additional information, please send an email to: OCE-Engagement@fda.hhs.gov